Athersys

$2.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 4:24 PM UTC today

Why Robinhood?

You can buy or sell Athersys and other stocks, options, and ETFs commission-free!

About ATHX

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH. The listed name for ATHX is Athersys, Inc. Common Stock.

CEO

Gil van Bokkelen

Employees

Headquarters

Cleveland, Ohio

Founded

1995

Market Cap

419.57M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.99M

High Today

$2.28

Low Today

$2.12

Open Price

$2.28

Volume

1.58M

52 Week High

$4.38

52 Week Low

$1.13

Collections

ATHX Earnings

-$0.11

-$0.07

-$0.04

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 16, After Hours